EP3624941A1 - Processus de fabrication d'un réseau avec microcanaux - Google Patents

Processus de fabrication d'un réseau avec microcanaux

Info

Publication number
EP3624941A1
EP3624941A1 EP18729055.6A EP18729055A EP3624941A1 EP 3624941 A1 EP3624941 A1 EP 3624941A1 EP 18729055 A EP18729055 A EP 18729055A EP 3624941 A1 EP3624941 A1 EP 3624941A1
Authority
EP
European Patent Office
Prior art keywords
droplet
microfluidic chip
capture agents
sol
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18729055.6A
Other languages
German (de)
English (en)
Inventor
Arnaud REITZ
Marcel Reichen
Bingqing Shen
Sami ELLOUZE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hifibio SAS
Original Assignee
Hifibio SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hifibio SAS filed Critical Hifibio SAS
Publication of EP3624941A1 publication Critical patent/EP3624941A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B81—MICROSTRUCTURAL TECHNOLOGY
    • B81C—PROCESSES OR APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OR TREATMENT OF MICROSTRUCTURAL DEVICES OR SYSTEMS
    • B81C99/00—Subject matter not provided for in other groups of this subclass
    • B81C99/0075—Manufacture of substrate-free structures
    • B81C99/0085—Manufacture of substrate-free structures using moulds and master templates, e.g. for hot-embossing
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B19/00—Other methods of shaping glass
    • C03B19/02—Other methods of shaping glass by casting molten glass, e.g. injection moulding
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C1/00—Ingredients generally applicable to manufacture of glasses, glazes, or vitreous enamels
    • C03C1/006—Ingredients generally applicable to manufacture of glasses, glazes, or vitreous enamels to produce glass through wet route
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C3/00—Glass compositions
    • C03C3/04—Glass compositions containing silica
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
    • B01L2200/0652—Sorting or classification of particles or molecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06—Fluid handling related problems
    • B01L2200/0673—Handling of plugs of fluid surrounded by immiscible fluid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/12—Specific details about manufacturing devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0822—Slides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0433—Moving fluids with specific forces or mechanical means specific forces vibrational forces
    • B01L2400/0436—Moving fluids with specific forces or mechanical means specific forces vibrational forces acoustic forces, e.g. surface acoustic waves [SAW]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
    • B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B81—MICROSTRUCTURAL TECHNOLOGY
    • B81B—MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES
    • B81B2201/00—Specific applications of microelectromechanical systems
    • B81B2201/05—Microfluidics
    • B81B2201/058—Microfluidics not provided for in B81B2201/051 - B81B2201/054
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B81—MICROSTRUCTURAL TECHNOLOGY
    • B81B—MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES
    • B81B2203/00—Basic microelectromechanical structures
    • B81B2203/03—Static structures
    • B81B2203/0323—Grooves
    • B81B2203/0338—Channels
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C2203/00—Production processes
    • C03C2203/20—Wet processes, e.g. sol-gel process
    • C03C2203/26—Wet processes, e.g. sol-gel process using alkoxides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2560/00—Nucleic acid detection

Definitions

  • the present invention relates to a process for manufacturing a microfluidic chip comprising solid glass obtained from a sol-gel solution, as well as to the obtained microfluidic chip and uses thereof.
  • microfluidic chips useful for cell sorting or for assessing biological reactions are made up of a silicone material, such as polydimethylsiloxane (PDMS).
  • PDMS polydimethylsiloxane
  • the mold used in the manufacturing process may also be made of such a flexible material (like PDMS).
  • microstructured objects which may be convenient for the field of microfluidics, may be made by a sol-gel process using a PDMS mold; this is notably described in US9266765.
  • the sol-gel process consists in preparing a solution containing precursors based on metal or metalloid elements (which may be organometallic compounds or metal salts) and one or more organic solvents, the resulting solution thereby forming a sol (which may also be designated sol-gel solution).
  • the sol already comprises water
  • the precursors contained in this sol-gel solution undergo, in part, a step of hydrolysis and a step of condensation, to form an oxide network entrapping the solvent, so as to form a gel.
  • the gel is then dried, to form at the end of said drying a monolithic object.
  • PDMS for microfluidic chips has many drawbacks: enclosure of particles, e.g. dust, is not uncommon;
  • thermoplastics materials also have a low compatibility with solvents. Besides, the surface quality is extremely dependent on the micromachining steps, which leave surface roughness that may induce a deterioration of emulsions injected therein. They are often incompatible with cleansing methods used for glass. Finally, it may be difficult to perform an efficient bonding of a piezoelectric material on such materials.
  • microfluidic chip there is thus a need for a process for manufacturing a microfluidic chip, which would be quick and easy to perform, at a high scalability. Moreover, there is a need for manufacturing a microfluidic chip in a stable material, suitable for high throughput processes, and which is less prone to particle enclosure. Said microfluidic chip would have to be usable at an industrial scale, and be in a material compatible with a bonding of a piezoelectric material. It would have to be compatible with cleansing methods used for glass, and preserve a good quality of the emulsions injected therein.
  • the inventors have discovered a specific process for manufacturing a solid glass microfluidic chip obtained from a sol-gel solution.
  • Said solid glass microfluidic chip may be particularly used for screening immune cells such as antibody-producing cells, T or NK cells, or neutrophils.
  • Said process is suitable for high throughput screening, and the material in use is stable and reduces coalescence or droplet breaking.
  • stable it is meant that the used material is chemically and mechanically stable. Indeed, it is not degraded over time; besides, it may be washed properly many times in order to be reused, without contamination risk.
  • it allows a long-term storage of the chips, particularly of the chips comprising biological samples, by avoiding pervaporation of water (thus avoiding the induction of droplets shrinkage) or oil comprised in said samples.
  • the present invention thus relates to a process for manufacturing a microfluidic chip comprising a solid material obtained from a sol-gel solution, the process comprising successively: a) casting a sol-gel solution made with tetraethyl orthosilicate onto a mold presenting a relief pattern and having a different thickness over the whole of the mold; b) gelling the sol-gel solution; c) unmolding and drying the gel obtained in b), so as to obtain a solid glass; and d) bonding said solid glass to a support, so as to obtain the microfluidic chip.
  • the invention also relates to a microfluidic chip obtainable by the process according to the invention.
  • the invention further provides for the use of a microfluidic chip obtainable by the process according to the invention for screening proteins, preferably antibodies.
  • the invention also relates to a process for screening cells producing a protein of interest, preferably immune cells, comprising the following steps: introducing emulsion droplets comprising cells producing a protein, preferably immune cells and more preferably antibody- or cytokine-secreting cells, and either beads coated with capture agents, or cells expressing capture agents at their surface or within the cell, into a microfluidic chip of the present invention;
  • sorting cells producing the protein of interest based on a specific optical signal.
  • Said signal may be fluorescent or luminescent. It may be detected for example after a laser excitation, with a suitable bandpass filter such as a photomultiplier or an avalanche photodiode. Such a process is for sorting cells, preferably immune cells, and is also called the "cell sorter process” or “cell sorting process”.
  • each emulsion droplet comprises (i) a single cell, preferably a single immune cell, and (ii) a single bead coated with capture agents or a suspension of magnetic beads coated with capture agents, or a single cell expressing capture agents.
  • the present invention also relates to a process for identifying nucleic acid sequences of interest, comprising the following steps: introducing emulsion droplets comprising cells into a microfluidic chip of the present invention, wherein each droplet comprises a single cell; putting a second droplet onto each emulsion droplet, wherein the second droplet comprises a defined number of beads coated with capture agents, preferably a single bead, and a reagents mixture, so that a fusion between each second droplet and each emulsion droplet is obtained, and then nucleic acid sequences of interest are delivered in said fusion; and
  • Such a process is also called the "barcoding process”.
  • the process for manufacturing a microfluidic chip comprising a solid material obtained from a sol- gel solution comprises successively: a) casting a sol-gel solution made with tetraethyl orthosilicate onto a mold presenting a relief pattern and having a different thickness over the whole of the mold; b) gelling the sol-gel solution; c) unmolding and drying the gel obtained in b), so as to obtain a solid glass; and d) bonding said solid glass to a support, so as to obtain the microfluidic chip.
  • a microfluidic chip comprises a substrate and a support, defining together at least a channel.
  • microfluidic it is generally meant that the transversal dimensions of the channel in which the droplets or fluid are intended to circulate are smaller than one millimeter and are comprised for example between 1 ⁇ and 1 mm.
  • the substrate of the microfluidic chip corresponds, in the present invention, to the solid material obtained from a sol-gel solution, i.e. to a solid glass.
  • the support of the microfluidic chip is preferably a glass slide or a wafer.
  • a microfluidic chip is generally a block containing channels with rectangular, elliptic or circular cross-sections.
  • the thickness of a microfluidic chip is generally less than 1 cm.
  • the channel is delimited by side walls defined in the substrate or in the support.
  • the side walls are defined in the substrate.
  • the relief pattern of the mold used in step a) of the process described above, thus forming the substrate of the microfluidic chip comprises protrusions, so that the gelled sol-gel solution of step b) comprises channels, such as microchannels or nanochannels.
  • the channel is elongated in a main direction.
  • the channel presents a height and a width, measured in a plan transversal to the main direction.
  • the height and/or the width are smaller than 1 mm, preferably comprised between 1 ⁇ and 1 mm.
  • the channel presents a square or a rectangular section in the plan transversal to the main direction.
  • the channel presents a circular or elliptical section in the plan transversal to the main direction.
  • the channel usually comprises an inlet to inject fluid and an outlet to collect fluid.
  • the channel is usually intended to allow flowing of a fluid along the main direction from the inlet toward the outlet.
  • the inlet of the channel can be connected to a reservoir of a fluid intended to flow in the channel.
  • the outlet of the channel can be connected to a reservoir to collect the fluid coming from the channel.
  • a microfluidic chip may comprise a plurality of channels, and comprises junctions between the channels.
  • the junction can be divergent, so that a fluid arriving in a first channel separates in two different channels after the junction.
  • junction can be convergent such that two fluids arrive from two different channels.
  • junctions are, for example, T junctions or flow-focusing junctions.
  • junctions are used to help the generation of droplets of an inner fluid in a carrier fluid, the carrier fluid being immiscible with the inner fluid.
  • the microfluidic chip may further comprise a filtration unit.
  • the microfluidic chip may further comprise an incubation chamber.
  • a microfluidic chip is typically intended to prepare successive droplets of an inner fluid, dispersed in an outer fluid.
  • the droplets comprise at least one medium dispersed or dissolved in the inner fluid, preferably at least a first medium dispersed and/or dissolved in the inner fluid, and a second medium dispersed and/or dissolved in the inner fluid.
  • a microfluidic chip may comprise one or more of the following feature(s), taken solely, or according to any technical possible combination: - a supply zone for introducing a fluid;
  • the microfluidic chip is preferably used as a biological assay system which delivers droplets each containing a single biological entity and at least a medium able to interact with the single biological entity.
  • An example of single biological entity is a single cell, such as a single immune cell, particularly a single antibody-producing cell or a single cytokine-producing cell.
  • the cell may be a prokaryotic (i.e. bacterial) cell, or a eukaryotic cell.
  • immuno cell it is meant an antibody- producing cell (i.e. a B cell), or a cytokine-producing cell such as a T cell, an NK cell, or a neutrophil.
  • Said single cell may be lysed or not lysed.
  • a cell producing a protein is typically isolated in a droplet of first fluid with a medium comprising a buffer.
  • a second medium comprising beads coated or grafted with capture agents, or cells expressing capture agents on their membrane surface or within the cell.
  • the first fluid and the second fluid are mixed, and typically added to a third fluid (such as a lipophilic or a fluorophilic fluid), to form the emulsion droplets.
  • the fluorophilic fluid may be HFE fluorinated oils from 3M Novec.
  • the microfluidic chip preferably comprises a chamber with an array of capture systems allowing droplets holding in place. It typically comprises an inlet and an outlet.
  • the beads used in the cell sorter process and in the barcoding process may be magnetic beads.
  • Magnetic beads may be made of iron or any other magnetic material. Magnetic beads are useful because they can concentrate the signal upon magnetic excitation, i.e. they can form a line which is easily detectable. Alternatively, they may be hydrogel beads.
  • the cell sorter process may use cells expressing capture agents instead of beads coated with capture agents, also called reporter cells.
  • Said cells may express capture agents at their surface, or may express capture agents within said cell. They may also be cells labeled with a fluorescent capture agent such as a fluorescent antibody.
  • Such cells may be prokaryote or eukaryote cells.
  • Prokaryote cells are notably bacterial cells. They may be wild-type, or engineered cells. By engineered, it is meant that the wild-type cell is modified by artificial genetic mutations.
  • An engineered cell may be a GMO (Gene Modified Organism).
  • the reporter cells are preferably CHO cells, such as CHO-S cells.
  • Capture agents include but are not necessarily limited to antibodies, antibody derivatives (such as scFv) and antigen binding fragments thereof, proteins, metabolites, as well as nucleic acid sequences.
  • the beads are functionalized so that they can be covalently or non-covalently associated with capture agents.
  • the beads comprise, for example, streptavidin covalently coupled to the surface of the beads, and as such are configured to form complexes with a biotinylated component, such as a biotinylated antibody or antigen binding fragment thereof.
  • the beads are coated with a monolayer of streptavidin.
  • the beads comprise functionalized groups on their surfaces, or chemical groups that are capable of being functionalized.
  • the beads are made of at least one organic polymer, which is able to form a hydrogel in water.
  • Said polymer may comprise acrylamide, polyethylene glycol or acrylate monomers.
  • the beads can be hydrophilic, and positively charged or negatively charged.
  • the beads can be provided pre-loaded with one or more capture agents onto their surfaces so that they can be used with the microfluidic chips to capture the proteins of interest such as antibodies and/or their sequences for which the one or more capture agents are specific.
  • the capture agents are antibodies, antibody derivatives or antigen binding fragments thereof.
  • the capture agents are nucleic acid sequences.
  • nucleic acid sequences it is meant DNA (including cDNA) or RNA.
  • the capture agents are DNA oligonucleotides, such as DNA oligonucleotides comprising from 2 to 40 nucleotides (nt), preferably from 5 to 25 nucleotides as capturing part. They are linked to functional DNA as barcode or specific DNA sequences used for sequencing and/or library amplification.
  • the DNA oligonucleotides which may be used have the following structure: (L)-(T7)-(Sbsl2/Sbs3)-(BCD)-(GSPs) wherein :
  • L is a linker allowing cleavage of the barcode sequence, for example under light exposure. L may be present or not; T7 is an In Vitro Transcription (IVT) sequence, which may be present or not. It is used for IVT in some applications, or as a PCR primer;
  • IVTT In Vitro Transcription
  • Sbsl2 and Sbs3 are lllumina sequences. They are used for library preparation for lllumina sequencing platform. They allow reading of each DNA strand, starting from the sense strand or the antisense strand; BCD is a barcode index used to generate the diversity of barcode builds, notably obtained from a composition comprising a defined number of different B, a defined number of different C and a defined number of different D.
  • This barcode sequence may be different as its length can vary and/or the number of indexes could vary (it could be ABCDEFG for example); and GSPs (Gene Specific Primer) is a sequence used for mRNA capture. It may be a Reverse Transcription (RT) primer for capturing VH and VL sequences with the same barcode, but it may also be a more general primer.
  • RT Reverse Transcription
  • each bead present in second droplets comprises a DNA oligonucleotide with the above structure in which BCD is a single barcode and GSPs is a fusion sequence between half of VH primer and half of VL primer.
  • the barcoding process uses a mixture of reagents which is adapted to a molecular biology technique.
  • Said molecular biology technique may be droplet Reverse Transcription (dRT), droplet Polymerase Chain Reaction (dPCR), dRT-PCR, quantitative droplet RT-PCR (qdRT-PCR), droplet In Vitro Transcription (dIVT), droplet DNA second strand synthesis (dDNA SSS), droplet Rolling Circle Amplification (dRCA).
  • the mixture of reagents may comprise a primer set, which is preferably gene specific, sequence specific, but which may also be adapted for random priming or whole priming (such as « Full RNA-seq » based on Poly A tailing of certain mRNA).
  • the microfluidic chip is a cell sorter.
  • the biological entities are put in contact with the beads coated or grafted with capture agents, or with the cells expressing said capture agents on their surface or within the cell.
  • the relevant droplets i.e. comprising the biological entities such as antibody-producing cells or cytokine-producing cells
  • the relevant droplets are then identified based on binding of the biological entity or its product (such as the antibodies or cytokines produced) and the beads coated or grafted with capture agents, or the cells expressing said capture agents on their surface or within the cell.
  • the single biological entity (such as the single antibody producing cell or the single cytokine producing cell) in each droplet can be recovered and further analyzed.
  • the cell sorter process thus comprises the following steps: introducing emulsion droplets comprising cells producing a protein, preferably immune cells and more preferably antibody- or cytokine-producing cells, and either beads coated with capture agents or cells expressing capture agents on their surface or within the cell, said emulsion droplets being optionally previously incubated in bulk, into a microfluidic chip of the present invention; and
  • sorting cells producing the protein of interest based on a specific optical signal By “previously incubated in bulk”, it is meant that the first fluid comprising the cells (such as immune cells and preferably antibody- or cytokine producing cells) in a medium comprising a buffer, and the second fluid comprising beads coated or grafted with capture agents, or cells expressing capture agents on their membrane surface or within the cell, are mixed and incubated, after forming emulsion droplets.
  • the first fluid and the second fluid are added to a third fluid (such as a lipophilic or a fluorophilic fluid), to form the emulsion droplets.
  • the incubation is performed. The incubation lasts for a time sufficient to allow binding of the produced protein to the capture agents, for example a few hours, for example from lh to 6h.
  • the cell sorter process comprises the following steps: - introducing emulsion droplets comprising cells producing a protein, preferably immune cells and more preferably antibody- or cytokine-producing cells, and either beads coated with capture agents or cells expressing capture agents on their surface or within the cell, into a microfluidic chip of the present invention;
  • the microfluidic chip is an array used for isolating a nucleic acid sequence of interest, particularly some DNA sequences of interest.
  • Said droplet array comprises wells, wherein each well comprises a droplet of a single biological entity.
  • Said biological entity may be a cell, preferably an immune cell, preferably an antibody-producing cell.
  • a second droplet comprising the beads preferably comprising a single bead, and a reagents mixture
  • a fusion i.e. mixture
  • fusion it is meant that a droplet of biological entity is mixed with a second droplet (i.e. comprising the beads), in order to form a bigger unique resulting droplet. Said fusion may be obtained by applying a high voltage.
  • the reagents mixture allows lysis of the biological entities, particularly of the cells of interest.
  • the fusion allows lysis of the biological entities, such as immune cells, and thereby linkage between the nucleic acid of interest, which is present in the biological entities, and the capture agents which are present on the beads.
  • the relevant wells i.e. comprising the biological entity such as cells of interest
  • the single biological entity such as the single antibody producing cell
  • the nucleic acid sequence of interest can be recovered too.
  • reporter cells are present in the second droplet, instead of beads and reagents mixture. Said reporter cells are as described above for the cell sorting process. This would correspond to a functional assay: indeed, each well where the biological entity reacts with the reporter cell would be identified.
  • the barcoding process of the invention thus comprises: introducing emulsion droplets comprising cells into a microfluidic chip of the present invention, wherein each droplet comprises a single cell;
  • the second droplet comprises a defined number of beads coated with capture agents, preferably a single bead, and a reagents mixture, so that a fusion between each second droplet and each emulsion droplet is obtained, and nucleic acid sequences of interest are delivered in said fusion.
  • capture agents preferably a single bead, and a reagents mixture
  • Sol-gel solution is conventionally taken to mean a solution comprising one or more metal or metalloid molecular precursors and one or more organic solvents.
  • mold presenting a relief pattern and having a different thickness over the whole of the mold it is meant a mold presenting a relief pattern which is typically complementary to nano- or microchannels (i.e. wherein the thickness is different over the whole of the mold).
  • the relief pattern of the mold comprises protrusions, so that the gelled sol-gel solution of step b) comprises microchannels or nanochannels.
  • Said mold is called a master mold; it is a mold of the microfluidic chip to be prepared.
  • it is a mold presenting a relief pattern of 1 ⁇ to 1 mm high.
  • the mold comprises a material of the family of epoxy-type negative near-UV photoresists or a polydimethylsiloxane material.
  • epoxy-type negative near-UV photoresist materials are octafunctional epoxidized novolac resins, and particularly photoresist materials based on the SU-8 family of photoresists made from Shell Chemical's EPON ® SU-8 epoxy resin. Said commercial resin directly in solution and ready-to-use is sold by Microchem.
  • the SU-8 family of photoresist materials is popular because it can provide relatively thick-film (usually from 500 nm to 1 mm) photoresist films at relatively low costs.
  • SU-8 In addition to being a relatively thick-film photoresist material, SU-8 is well suited for acting as a mold for electroplating because of its relatively high thermal stability (Tg greater than 200°C for the cross-linked or post-exposure photoresist material).
  • the process according to the present invention further comprises, before step a), a step of preparing the mold.
  • the protocol for preparing the mold may be as described in the document "SU-8 2000, Permanent Epoxy Negative Photoresist, processing guidelines" (available under the following link: http://www.microchem.com/pdf/SU-82000DataSheet2025thru2075Ver4.pdf).
  • substrate pretreat the substrate should be cleaned and dried prior to applying the photoresist.
  • the substrate may typically be cleaned with a piranha wet etch (using H2S04 & H202) followed by a deionized water rinse; or with reactive ion etching (RIE); coat: the substrate is coated with the photoresist under adequate spin conditions; edge bead removal (EBR): during the spin coat process step, a build-up of photoresist may occur on the edge of the substrate. In order to minimize contamination of the hotplate, this thick bead should be removed.
  • RIE reactive ion etching
  • solvent such as MicroChem's EBR PG
  • the mold which may be used may also be a PDMS mold. Such a material is more flexible and allows an easy peeling.
  • the process of the invention comprises successively: a) casting a sol-gel solution made with tetraethyl orthosilicate onto a mold presenting a relief pattern and having a different thickness over the whole of the mold; b) gelling the sol-gel solution; c) unmolding and drying the gel obtained in b), so as to obtain a solid glass; and d) bonding said solid glass to a support, so as to obtain the microfluidic chip.
  • the process of the invention comprises a step of preparing the sol-gel solution by a method comprising: i) mixing tetraethyl orthosilicate (TEOS) with ethanol and water;
  • step ii) adding hydrochloric acid to the mixture of step i).
  • the molar ratios of TEOS:ethanol:water:hydrochloric acid is around 0.8-1.2: 9-11: 2.5-4.5: 0.002- 0.005;
  • step iii) refluxing the mixture of step ii) at a temperature of at least 60°C for hydrolyzing tetraethyl orthosilicate.
  • the temperature is comprised between 65°C and 100°C.
  • step iii) lasts between lh and 2h; iv) cooling the resulting mixture of step iii) at ambient temperature; and iv) adding an aqueous solution of ammonium hydroxide to the cooled mixture of step iv), and stirring to obtain the sol-gel solution.
  • sol-gel solution is typically described in Huang & Chou, Ceramics International 29 (2003), 485-493 (Studies on the spin coating process of silica films).
  • Steps i) to iii) above correspond to the "sol" synthesis, i.e. to a hydrolysis reaction.
  • Steps iv) and v) above correspond to the condensation-polymerization reaction.
  • the sol-gel solution prepared with TEOS is casted onto the required mold; this corresponds to step a). Said solution is still liquid.
  • the sol-gel solution prepared with TEOS is casted onto a mold of the object to be manufactured, intended, after gelling and drying, to constitute the microfluidic chip.
  • This casting step, or pouring step, is thus different from an injection step.
  • step b said sol-gel solution is gelled.
  • the gel obtained in b) is then unmolded and dried; this is step c).
  • the drying step may be performed according to two different ways: evaporative drying: the gel obtained in b), once unmolded, is dried 2 to 3 weeks under a controlled atmosphere (e.g. nitrogen); or supercritical drying: the gel obtained in b) is put in a sealed chamber and under pressure. Carbon dioxide is then added, and forms a supercritical fluid (i.e. which is liquid and gaseous at the same time). It prevents constraints to appear in the material, and thus prevents cracks to happen.
  • step c a solid glass is obtained.
  • step d said solid glass is bonded to a support, so as to obtain the microfluidic chip; this is step d).
  • the support used in step d) is a glass slide, or a substrate made up of a material which is coated with a Si02 layer using a sputtering technique.
  • step d) comprises anodic bonding for glass or Si02 coated substrates, or plasma bonding or thermal bonding.
  • step d) comprises anodic bonding for Si02 coated substrates, performed with a piezoelectric material, such as lithium niobate or lithium tantalate substrate.
  • said step d) is performed at a temperature comprised between room temperature (around 20°C) and 400°C.
  • anodic bonding is used to identify the bonding of the solid glass substrate of the invention, to glass or silicon supports, preferably Si02 coated substrates, with a high content of alkali oxides.
  • the bonding occurs when the two substrates are heated after being brought in contact and an electric field is applied.
  • oxides dissociate and the mobile alkali ions are driven by the electric field into the glass, creating an oxygen rich layer notably at the silicon-glass interface.
  • Oxygen ions are driven by the electric field to the silicon surface and produce oxidation of Si. The resulting bond strength is very high and the process is irreversible.
  • the present invention also relates to a microfluidic chip obtainable by the process according to the invention.
  • Said microfluidic chip may be used for screening proteins, preferably antibodies.
  • said microfluidic chip is a static droplet array or a droplet sorter, preferably a surface acoustic wave droplet sorter.
  • the present invention also relates to a process for screening cells producing a protein of interest, preferably immune cells, comprising the following steps:
  • emulsion droplets comprising cells producing a protein, preferably immune cells, and either beads coated with capture agents or cells expressing capture agents at their surface or within the cell, into a microfluidic chip of the present invention
  • Said signal may be fluorescent or luminescent. It may be detected for example after a laser excitation, with a suitable bandpass filter such as a photomultiplier or an avalanche photodiode.
  • a suitable bandpass filter such as a photomultiplier or an avalanche photodiode.
  • each emulsion droplet comprises (i) a single cell, preferably a single immune cell and more preferably a single antibody- or cytokine-producing cell, and (ii) preferably a single bead coated with capture agents or a suspension of magnetic beads coated with capture agents, or a single cell expressing capture agents.
  • the present invention also relates to a process for identifying nucleic acid sequences of interest, comprising the following steps: introducing emulsion droplets comprising cells into a microfluidic chip of the present invention, wherein each droplet comprises a single cell;
  • the second droplet comprises a defined number of beads coated with capture agents, preferably a single bead, and a reagents mixture, so that a fusion between each second droplet and each emulsion droplet is obtained, and nucleic acid sequences of interest are delivered in said fusion.
  • the fusion may be obtained by applying a voltage;

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Physics & Mathematics (AREA)
  • Manufacturing & Machinery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Fluid Mechanics (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne un processus de fabrication d'une puce microfluidique comprenant un matériau solide obtenu à partir d'une solution sol-gel, le processus comprenant successivement :a) le coulage d'une solution sol-gel constituée d'orthosilicate de tétraéthyle sur un moule présentant un motif en relief et ayant une épaisseur différente sur l'ensemble du moule;b) la gélification de la solution sol-gel; c) le démoulage et le séchage du gel obtenu dans b), de manière à obtenir un verre solide; et d) la liaison dudit verre solide à un support, de manière à obtenir la puce microfluidique.
EP18729055.6A 2017-05-18 2018-05-18 Processus de fabrication d'un réseau avec microcanaux Withdrawn EP3624941A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17305580.7A EP3403724A1 (fr) 2017-05-18 2017-05-18 Procédé de fabrication d'un réseau comportant des microcanaux
PCT/EP2018/063224 WO2018211123A1 (fr) 2017-05-18 2018-05-18 Processus de fabrication d'un réseau avec microcanaux

Publications (1)

Publication Number Publication Date
EP3624941A1 true EP3624941A1 (fr) 2020-03-25

Family

ID=59388016

Family Applications (2)

Application Number Title Priority Date Filing Date
EP17305580.7A Withdrawn EP3403724A1 (fr) 2017-05-18 2017-05-18 Procédé de fabrication d'un réseau comportant des microcanaux
EP18729055.6A Withdrawn EP3624941A1 (fr) 2017-05-18 2018-05-18 Processus de fabrication d'un réseau avec microcanaux

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP17305580.7A Withdrawn EP3403724A1 (fr) 2017-05-18 2017-05-18 Procédé de fabrication d'un réseau comportant des microcanaux

Country Status (4)

Country Link
US (1) US20210154674A1 (fr)
EP (2) EP3403724A1 (fr)
CN (1) CN110650802A (fr)
WO (1) WO2018211123A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3098128B1 (fr) * 2019-07-05 2023-11-17 Commissariat Energie Atomique Dispositif microfluidique comportant une microgoutte présentant une matrice sol-gel.
CN113117766B (zh) * 2021-04-06 2022-08-02 杭州电子科技大学 一种用于微流控的声学镊子
CN113233916B (zh) * 2021-05-20 2022-03-11 山东大学 一种基于微流体芯片的多孔氧化铝微纤维的制备装置和方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810547A (en) * 1986-03-26 1989-03-07 Nippon Sheet Glass Co., Ltd. Substrate with fine grooves and method for manufacturing the same
EP1364763A1 (fr) * 2001-02-01 2003-11-26 Nippon Sheet Glass Co., Ltd. Procede de fabrication d'article a forme de surface specifiee
JP4654458B2 (ja) * 2004-12-24 2011-03-23 リコープリンティングシステムズ株式会社 シリコン部材の陽極接合法及びこれを用いたインクジェットヘッド製造方法並びにインクジェットヘッド及びこれを用いたインクジェット記録装置
CN102186992A (zh) * 2008-08-15 2011-09-14 康奈尔大学 用于快速鉴定与特定化学靶点结合的核酸的装置
KR101106022B1 (ko) * 2009-10-28 2012-01-17 공주대학교 산학협력단 세포 기반 주화성 키트 및 이의 제조 방법
US9586810B2 (en) * 2010-07-30 2017-03-07 Sony Corporation Polymeric substrate having an etched-glass-like surface and a microfluidic chip made of said polymeric substrate
FR2980789B1 (fr) * 2011-09-29 2013-10-25 Commissariat Energie Atomique Procede de fabrication d'un objet a partir d'une solution sol-gel
CA3216609C (fr) * 2012-08-14 2024-05-14 10X Genomics, Inc. Compositions de microcapsule et procedes
CN103087899B (zh) * 2013-01-17 2014-08-20 湖南大学 一种基于核酸适体的可捕获癌细胞的微流控芯片及其制备和癌细胞的分离方法
CN103357452B (zh) * 2013-06-29 2015-08-12 南昌大学 聚多巴胺/氧化石墨烯/bsa的制备方法
JP2016535994A (ja) * 2013-08-05 2016-11-24 ザ・ジョンズ・ホプキンス・ユニバーシティ 階層的シリカナノ膜の作製及びその核酸の固相抽出への使用
EP3730929A1 (fr) * 2013-08-19 2020-10-28 University Of Houston Rapporteurs phosphorescents
US10947587B2 (en) * 2013-11-05 2021-03-16 The Regents Of The University Of California Single-cell forensic short tandem repeat typing within microfluidic droplets
CN103642755B (zh) * 2013-11-06 2016-06-29 上海交通大学 从血液中分离循环肿瘤细胞的方法
AU2015247462A1 (en) * 2014-04-17 2016-11-03 President And Fellows Of Harvard College Methods and systems for droplet tagging and amplification
JP2017532024A (ja) * 2014-09-09 2017-11-02 ザ・ブロード・インスティテュート・インコーポレイテッド コンポジット単一細胞核酸分析のための液滴ベースの方法および機器
CN104792767B (zh) * 2015-05-08 2017-11-17 厦门大学 一种用于溶胶法sers检测的微流控芯片及其使用方法
CN105233893A (zh) * 2015-11-02 2016-01-13 华东理工大学 基于微流控芯片改性技术制备微液滴的方法
CN105439419A (zh) * 2015-11-16 2016-03-30 徐州中韵新材料科技有限公司 一种溶胶-凝胶法制备低熔点四元bzbs玻璃的方法
CN105807047B (zh) * 2016-04-15 2018-12-11 上海交通大学 基于核酸序列编码的elisa检测芯片及其制备和应用
CN106187208A (zh) * 2016-07-20 2016-12-07 合肥毅创钣金科技有限公司 一种含纳米石墨的大功率led散热氮化铝陶瓷基板
CN106498040B (zh) * 2016-10-12 2018-10-23 浙江大学 一种分子标记微珠及基于该分子标记微珠的高通量单细胞测序方法

Also Published As

Publication number Publication date
CN110650802A (zh) 2020-01-03
US20210154674A1 (en) 2021-05-27
WO2018211123A1 (fr) 2018-11-22
EP3403724A1 (fr) 2018-11-21

Similar Documents

Publication Publication Date Title
US11732287B2 (en) Sequencing of nucleic acids via barcoding in discrete entities
US10427160B2 (en) Rapid and continuous analyte processing in droplet microfluidic devices
EP1883693B1 (fr) Dispositifs et methodes permettant d'analyser des cellules individuelles
US20220034869A1 (en) Multi-stage, multiplexed target isolation and processing from heterogeneous populations
CN101952411B (zh) 用于核酸定量分析的反应器
US6958217B2 (en) Single-stranded polynucleotide tags
CN115928221A (zh) 单细胞核酸序列分析
US11753743B2 (en) High-throughput single-cell polyomics
EP3624941A1 (fr) Processus de fabrication d'un réseau avec microcanaux
EP1716404A1 (fr) Procede et dispositif servant manipuler des liquides dans des systemes microfluidiques
US20230227901A1 (en) Selective Addition of Reagents to Droplets
CA2473308C (fr) Dosage et kit d'analyse d'expression genique
RU2804754C2 (ru) Иммобилизация в проточных кюветах
US20230264186A1 (en) Devices and methods for tissue sample processing
WO2021128052A1 (fr) Kit pour construire une banque de séquençage bcr de cellules isolées humaines et ses applications
US20230347312A1 (en) Systems and methods for liquid deposition
EP4186981A1 (fr) Isolation et manipulation directes parallèles d'acide nucléique à partir de cellules cultivées dans des gouttelettes de nanolitre
WO2021128036A1 (fr) Kit permettant de construire une bibliothèque de séquençage de tcr monocellulaire humain et son utilisation
WO2021128035A1 (fr) Procédé de séquençage à haut débit du transcriptome d'une cellule unique et kit d'analyses
JP2023554399A (ja) マイクロ流体方法及びシステム
Chapin Encoded hydrogel microparticles for high-throughput molecular diagnostics and personalized medicine
JP2021534956A (ja) 安定なジェットからの単分散粒子に誘発される液滴の形成
Wang et al. From biochips to laboratory-on-a-chip system
Wang et al. 5From biochips to laboratory-on

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20201126

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20231201